成人焦虑障碍筛查:美国预防服务工作组推荐声明
美国预防服务工作组(USPSTF)基于系统综述评估无症状成人焦虑障碍筛查的获益与危害。结论为对19岁及以上成人(含孕产妇)筛查有中度净获益(B推荐),对65岁及以上老年人证据不足(I声明)。
要点
- USPSTF推荐对19岁及以上成人(含孕产妇)筛查焦虑障碍(B推荐)。
- 对65岁及以上老年人筛查焦虑障碍的获益与危害证据不足(I声明)。
核心结论
- USPSTF以中度确定性认为,对成人(含孕产妇)筛查焦虑障碍有中度净获益。
- USPSTF认为对老年人筛查焦虑障碍的证据不足。
研究设计与样本
- USPSTF委托系统综述,评估无症状成人焦虑障碍筛查的获益与危害。
主要发现
- USPSTF以中度确定性得出成人(含孕产妇)筛查焦虑障碍有中度净获益的结论。
- USPSTF认为老年人筛查焦虑障碍的获益与危害平衡证据不足。
关键数值与推荐
- 推荐对成人(含孕产妇)筛查焦虑障碍(B推荐)。
- 对老年人筛查焦虑障碍的当前证据不足以评估获益与危害平衡(I声明)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Anxiety disorders are commonly occurring mental health conditions. They are often unrecognized in primary care settings and substantial delays in treatment initiation occur. OBJECTIVE: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for anxiety disorders in asymptomatic adults. POPULATION: Asymptomatic adults 19 years or older, including pregnant and postpartum persons. Older adults are defined as those 65 years or older. EVIDENCE ASSESSMENT: The USPSTF concludes with moderate certainty that screening for anxiety disorders in adults, including pregnant and postpartum persons, has a moderate net benefit. The USPSTF concludes that the evidence is insufficient on screening for anxiety disorders in older adults. RECOMMENDATION: The USPSTF recommends screening for anxiety disorders in adults, including pregnant and postpartum persons. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety disorders in older adults. (I statement).
引用
- Barry MJ, Nicholson WK, Silverstein M, et al. Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2023. PMID: 37338866. doi:10.1001/jama.2023.9301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。